DEUTSCHE BANK AG\ - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 18 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2015$18,987,000
-48.6%
4,943,000
-50.3%
0.01%
-47.8%
Q4 2014$36,944,000
-9.8%
9,943,000
-41.3%
0.02%
-8.0%
Q3 2014$40,959,000
+42.9%
16,943,000
+30.1%
0.02%
+31.6%
Q2 2014$28,666,000
+116.0%
13,023,000
+163.3%
0.02%
+111.1%
Q1 2014$13,272,000
+14.4%
4,947,000
+6.0%
0.01%
+12.5%
Q4 2013$11,599,000
+6.3%
4,666,0000.0%0.01%0.0%
Q3 2013$10,909,0004,666,0000.01%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2013
NameSharesValueWeighting ↓
WOLVERINE ASSET MANAGEMENT LLC 35,441,000$87,701,0002.49%
EQUITEC SPECIALISTS, LLC 3,112,000$7,761,0001.89%
WHITEBOX ADVISORS LLC 11,246,000$28,045,0000.82%
FMR LLC 6,000,000$14,963,0000.00%
WELLS FARGO & COMPANY/MN 300,000$730,0000.00%
BANK OF AMERICA CORP /DE/ 5,000$12,0000.00%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders